Search Within
P3338
Applied Filters:
Keyword:'P3338'
Showing 1-13 of 13 results for "P3338" within Papers
Dongwoo Kim et al.
Analytical chemistry, 81(21), 9183-9187 (2009-10-31)
We report the use of electroless gold deposition as a light scattering signal enhancer in a multiplexed, microarray-based scanometric immunoassay using gold nanoparticle probes. The use of gold development results in greater signal enhancement than the typical silver development, and
Structure, function, and regulation of the enzyme activity of prostate-specific antigen.
Lilja H
World Journal of Urology, 11(4), 188-191 (1993)
Microarray-based multiplexed scanometric immunoassay for protein cancer markers using gold nanoparticle probes.
Kim D
Analytical Chemistry, 81(21), 183-187 (2009)
Steven P Balk et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21(2), 383-391 (2003-01-15)
Prostate-specific antigen (PSA) is an androgen-regulated serine protease produced by both prostate epithelial cells and prostate cancer (PCa) and is the most commonly used serum marker for cancer. It is a member of the tissue kallikrein family, some of the
Barry Lutz et al.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 56(4), 371-379 (2007-12-12)
Surface-enhanced Raman scattering (SERS) nanoparticles are emerging as a new approach for optical detection of biomolecules. In a model assay in formalin-fixed paraffin-embedded (FFPE) prostate tissue sections, we detect prostate-specific antigen (PSA) using antibody (Ab) conjugated to composite organic-inorganic nanoparticles
D A Armbruster
Clinical chemistry, 39(2), 181-195 (1993-02-01)
Prostate-specific antigen (PSA) is a glycoprotein produced exclusively by prostatic tissue. PSA's absolute tissue specificity makes it valuable as a forensic marker and, more important, as a tumor marker for prostatic cancer. Prostatic cancer is prevalent in the older male
Chun-Jen Hsiao et al.
Disease markers, 2016, 8915809-8915809 (2016-04-12)
Glycans of prostate-specific antigen (PSA) in prostate cancer were found to be different from that in benign disease. It is difficult to analyze heterogeneous PSA glycoforms in each individual specimen because of low protein abundance and the limitation of detection
Blocking serine protease activity prevents semenogelin degradation leading to hyperviscous semen in humans.
Anamthathmakula, et al.
Biology of reproduction, 106, 879-887 (2023)
Pt nanoparticle label-mediated deposition of Pt catalyst for ultrasensitive electrochemical immunosensors
Zhang J, et al.
Biosensors And Bioelectronics, 26(2), 418-423 (2010)
A M Zhou et al.
Clinical chemistry, 39(12), 2483-2491 (1993-12-01)
Prostate-specific antigen (PSA) in serum is primarily complexed with alpha 1-antichymotrypsin (alpha 1-ACT). However, 12-15% of prostate cancer (PCa) patients present with the predominant form being uncomplexed (free) PSA (Lilja et al., Clin Chem 1991;37:1618-24). We report that commercial immunoassays
Agnieszka Stolarczyk et al.
Sensors (Basel, Switzerland), 22(4) (2022-02-27)
The detection of chemicals is a fundamental issue of modern civilisation, however existing methods do not always achieve the desired sensitivity. Preconcentrators, which are devices that allow increasing the concentration of the intended analyte via e.g., adsorption/desorption, are one of
Raman nanoparticle probes for antibody-based protein detection in tissues
Lutz B, et al.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 56(4), 371-379 (2008)
Usefulness of total PSA value in prostate diseases diagnosis
Prcic A, et al.
Acta Informatica Medica, 24(3), 156-156 (2016)
Page 1 of 1